NCT00199212View on ClinicalTrials.gov

PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Carcinoma Breast Stage IV
Interventions
DRUG

Combination of trastuzumab and PS-341

Trastuzumab and velcade are used according standard procedure

Trial Locations (1)

1000

Jules Bordet Institute, Brussels

Sponsors
All Listed Sponsors
lead

Jules Bordet Institute

OTHER